Sergio Cuello

Sergio Cuello has extensive experience in the pharmaceutical industry, particularly in oncology marketing. Sergio currently holds the position of Head of Marketing, Oncology at Recordati Rare Diseases Inc. Sergio previously worked as the Senior Director of Marketing at Medexus Pharmaceuticals, where they were responsible for the commercial launch of treosulfan as a treatment for acute myeloid leukemia and myelodysplastic syndrome. Prior to that, Sergio served as a Senior Director of Oncology Marketing at Kyowa Kirin, overseeing the marketing strategies for Poteligeo and Sancuso. Sergio also worked at Bayer in various roles, including Deputy Director of US Oncology Marketing and Regional Manager of Oncology in Latin America. Sergio's roles at Bayer included leading the launch of Stivarga for hepatocellular carcinoma and managing marketing strategies for Nexavar in renal cell carcinoma and hepatocellular carcinoma. Sergio also played a significant role in medical education and grants at Bayer.

Sergio Cuello has a Bachelor's degree in Counseling Psychology from Toccoa Falls College, which they obtained from 1992 to 1997. Sergio then pursued a Master of Business Administration (MBA) with a specialization in Marketing from Centenary University, completing it from 2008 to 2010.

In terms of additional certifications, Sergio obtained a certification in Digital Marketing: Customer Engagement, Social Media, Planning & Analytics from Emeritus in November 2022. Sergio obtained this certification on three separate occasions. Additionally, they obtained a certification in Leadership Mindsets from LinkedIn in January 2021. Sergio also acquired a certification in Strategic Thinking from LinkedIn in November 2020.

Furthermore, Sergio has a certification in Digital Marketing and Social Media Analytics from the MIT Sloan School of Management, although the specific month of completion is not provided.